Status:
COMPLETED
Non-invasive Brain Stimulation and Injury Risk Biomechanics
Lead Sponsor:
University of Georgia
Conditions:
Concussion, Mild
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test the effects of repetitive transcranial magnetic stimulation (theta burst stimulation) on movement biomechanics (jump landing) among individuals with and with...
Detailed Description
The overall goal of the project is to determine how repetitive transcranial magnetic stimulation (theta burst stimulation) influences movement among individuals with and without a concussion history. ...
Eligibility Criteria
Inclusion
- All participants
- self-report to be physically active at least 90 minutes per week
- aged 18-35 years old
- self-report cleared for sports and physical activity
- Concussion history group
- \- self-report experiencing a concussion with the National Institute of Health common data element form
- No concussion history group - self-report not experiencing a concussion with the National Institute of Health common data element form
Exclusion
- All Participants
- self-report attention deficit disorder and/or attention deficit hyperactivity disorder
- self-report uncorrected vision problems (not included color blindness)
- self-reported history of neurological disease
- self-reported history of seizures/syncope or family history of epilepsy
- self-reported history of frequent severe headaches or migraine.
- self-reported history of respiratory or heart disease.
- self-reported structural brain lesions (e.g., stroke)
- self-reported increased intracranial pressure, such as after infarctions or trauma.
- self-reported currently using antidepressants, neuroleptic medication, medication that lowers seizure threshold, or any other medication that would interfere with testing.
- self-reported currently experiencing a high fever (day of testing; \>102.9 degrees)
- self-reported currently undergoing immunosuppressive therapy
- pregnancy
- metal anywhere in the head (except the mouth).
- any electronic implant, such as a cardiac pacemakers, cochlear implant, or deep brain stimulator.
- any implanted medication pump or intracardiac lines.
- self-report not being cleared for sport/physical activity by a medical practitioner (i.e., must be cleared by a medical practitioner to participate if the participant had previous traumatic musculoskeletal injury)
- students working directly in the PI's lab (concussion laboratory, biomechanics laboratory)
- NCAA athletes
- Concussion history group
- \- ≥13 symptom severity on the Sport Concussion Assessment Tool (22 total symptoms are graded on a scale of 0-6. Any symptom with a score \>0 \[1-6\], is summed to get symptom severity).
Key Trial Info
Start Date :
November 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06093295
Start Date
November 3 2023
End Date
May 30 2024
Last Update
January 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Georgia
Athens, Georgia, United States, 30602